Enabling long-lasting cell therapy for diabetes without injection
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Is immunoengineering the key to ensuring that cell therapies can treat disease?
Medicine by Design-funded research program that aims to generate next-generation immunomodulation therapies has seeded a Canadian biotechnology success story with the closing of an $85-million (U.S.) Series A financing.
Nanotechnology expert brings rich experience in academia and industry to the Institute of Biomedical Engineering.
Nine funded projects span synthetic biology, computational modelling, immunoengineering and organoids